ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 41 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | – | 5,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,111,590 | $7,876,000 | 3.50% |
| Abingworth LLP | 603,740 | $2,234,000 | 1.04% |
| BVF INC/IL | 862,069 | $3,216,000 | 0.51% |
| SABBY MANAGEMENT, LLC | 922,562 | $3,441,000 | 0.15% |
| TFS CAPITAL LLC | 360,260 | $1,344,000 | 0.11% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 175,980 | $656,000 | 0.04% |
| Tekla Capital Management LLC | 113,100 | $422,000 | 0.04% |
| Visium Asset Management, LP | 598,443 | $2,232,000 | 0.04% |
| A.R.T. Advisors, LLC | 101,905 | $380,000 | 0.02% |
| B. Riley Wealth Management, Inc. | 6,300 | $23,000 | 0.02% |